Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

9.73
Delayed Data
As of Mar 29
 +0.43 / +4.62%
Today’s Change
8.61
Today|||52-Week Range
15.45
-6.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues36.2M39.3M32.3M41.7M
 
 
 
 
 
Cost of Goods Sold4.1M3.7M2.7M2.5M
 
 
 
 
 
Depreciation And Amortization3.7M4.0M3.9M2.8M
 
 
 
 
 
 
Operating ExpensesGross Income28.3M31.6M25.7M36.3M
 
 
 
 
 
General Expenses14.8M19.1M21.0M20.5M
 
 
 
 
 
Other Operating Expenses0.000.000.002.9M
 
 
Research And Development5.4M7.7M8.2M13.0M
 
 
 
 
 
Total Operating Expenses22.7M26.8M27.6M28.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income13.4M12.5M4.7M12.9M
 
 
 
 
 
Extraordinary Credit0.000.000.003.6M
 
 
Extraordinary Charge-7.9M-24.2M-21.0M0.00
 
 
 
 
Interest Expense On Debt2.0M3.1M2.1M252.4K
 
 
 
 
 
Other Expenses-2.9M1.7M-1.1M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income764.0K-12.7M-19.0M17.5M
 
 
 
 
 
Income Taxes-7.1M-7.5M-3.5M-12.9M
 
 
 
 
 
Net Income-6.4M-20.2M-22.5M4.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.2M41.2M41.2M41.3M
 
 
 
 
 
Shares To Calculate EPS Diluted41.2M41.2M41.2M42.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.49-$0.54$0.11
 
 
 
 
 
EPS Diluted-$0.15-$0.49-$0.54$0.11